U.S. flag

An official website of the United States government

NM_007078.3(LDB3):c.1535A>C (p.Gln512Pro) AND Cardiovascular phenotype

Germline classification:
Likely benign (1 submission)
Last evaluated:
Apr 9, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000619692.11

Allele description [Variation Report for NM_007078.3(LDB3):c.1535A>C (p.Gln512Pro)]

NM_007078.3(LDB3):c.1535A>C (p.Gln512Pro)

Gene:
LDB3:LIM domain binding 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.2
Genomic location:
Preferred name:
NM_007078.3(LDB3):c.1535A>C (p.Gln512Pro)
Other names:
p.Q512P:CAG>CCG
HGVS:
  • NC_000010.11:g.86716630A>C
  • NG_008876.1:g.53067A>C
  • NM_001080114.2:c.1205A>C
  • NM_001080116.1:c.*17256A>C
  • NM_001171610.2:c.1550A>C
  • NM_001368064.1:c.1346A>C
  • NM_001368065.1:c.1346A>C
  • NM_001368066.1:c.1394A>C
  • NM_007078.3:c.1535A>CMANE SELECT
  • NP_001073583.1:p.Gln402Pro
  • NP_001165081.1:p.Gln517Pro
  • NP_001354993.1:p.Gln449Pro
  • NP_001354994.1:p.Gln449Pro
  • NP_001354995.1:p.Gln465Pro
  • NP_009009.1:p.Gln512Pro
  • NP_009009.1:p.Gln512Pro
  • LRG_385t1:c.1535A>C
  • LRG_385t2:c.*17256A>C
  • LRG_385:g.53067A>C
  • LRG_385p1:p.Gln512Pro
  • NC_000010.10:g.88476387A>C
  • NM_001080114.1:c.1205A>C
  • NM_001080115.1:c.*17256A>C
  • NM_001171610.1:c.1550A>C
  • NM_007078.2:c.1535A>C
  • c.1535A>C
Protein change:
Q402P
Links:
dbSNP: rs138951890
NCBI 1000 Genomes Browser:
rs138951890
Molecular consequence:
  • NM_001080116.1:c.*17256A>C - genic downstream transcript variant - [Sequence Ontology: SO:0002152]
  • NM_001080114.2:c.1205A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001171610.2:c.1550A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368064.1:c.1346A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368065.1:c.1346A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001368066.1:c.1394A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007078.3:c.1535A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000737327Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Apr 9, 2019)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.

Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH.

Genet Med. 2014 Aug;16(8):601-8. doi: 10.1038/gim.2013.204. Epub 2014 Feb 6.

PubMed [citation]
PMID:
24503780

Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy.

Nouhravesh N, Ahlberg G, Ghouse J, Andreasen C, Svendsen JH, Haunsø S, Bundgaard H, Weeke PE, Olesen MS.

Mol Genet Genomic Med. 2016 Nov;4(6):617-623.

PubMed [citation]
PMID:
27896284
PMCID:
PMC5118206

Details of each submission

From Ambry Genetics, SCV000737327.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024